RBC Reiterates Merck (MRK) Outperform, Notes Investor Concerns Over “Modest Premium” [Yahoo! Finance]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Yahoo! Finance
RBC Reiterates Merck (MRK) Outperform, Notes Investor Concerns Over “Modest Premium” On March 25, RBC reiterated an Outperform rating on Merck & Co., Inc. (NYSE:MRK) with a $142 price target. After the company held a conference call to discuss its proposed acquisition of Terns Pharmaceuticals (TERN), RBC Capital Markets analyst Trung Huynh said the “prevailing feedback” from investors has been one of disappointment. He noted that investors questioned the deal premium and why Terns would agree to what was described as a “modest premium” for a “high-probability asset.” At the same time, Merck received positive comments. Investors viewed the company “as a savvy capital allocator addressing their upcoming patent cliff.” Still, the firm said some investors do not see this as the final outcome. There is an expectation that competing bidders could emerge or that shareholders may reject the deal altogether. Merck & Co., Inc. (NYSE:MRK) is a global healthcare company that develops and d
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Jim Cramer on Merck & Co.: “If We're Really Going Into an Oil Shock-Induced Slowdown, I Think This One's Likely an Outperformer”” [Yahoo! Finance]Yahoo! Finance
- Merck Targets Post Keytruda Future With US$6.7b Terns Acquisition [Yahoo! Finance]Yahoo! Finance
- Agilent receives FDA approval for PD-L1 1HC 22C3 pharmDx [Yahoo! Finance]Yahoo! Finance
- Merck's deal for Terns sparks debate over a possible biotech bidding war [Yahoo! Finance]Yahoo! Finance
- Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline [MSNBC.com]MSNBC.com
MRK
Earnings
- 2/3/26 - Beat
MRK
Sec Filings
- 3/27/26 - Form SCHEDULE
- 3/12/26 - Form 3
- 2/24/26 - Form 10-K
- MRK's page on the SEC website